Pruritus Therapeutics Market Share

Market Share of Pruritus Therapeutics Industry

The pruritus therapeutics market is fragmented due to the presence of many companies operating globally and regionally. The competitive landscape includes an analysis of a few international and local companies that hold market shares and are well known. Some key players are Actavis, AbbVie Inc., Astellas Pharma Inc., Cara Therapeutics, EPI Health LLC, Galderma Laboratories LP, Ocera Therapeutics Inc., and Pfizer Inc., Sanofi, Trevi Therapeutics, among others.

Pruritus Therapeutic Market Leaders

1. Cara Therapeutics

2. EPI Health, LLC

3. Gladerma Laboratories, LP.

4. Sanofi SA

5. AbbVie Inc.

*Disclaimer: Major Players sorted in no particular order